Why HMG-CoA reductase escapes feedback inhibition in hypercholesterolemia: A mechanistic hypothesis integrating metabolic, genetic and post-translational dysregulation

Cholesterol synthesis is physiologically constrained by negative feedback inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR). Paradoxically, many patients with familial or metabolic hypercholesterolemia exhibit persistently elevated hepatic HMGCR activity despite intracellular sterol accumulation. This conceptual hypothesis proposes that hypercholesterolemia represents a state of “metabolic feedback resistance,” wherein the normal sterol-sensing and degradation machinery of HMGCR is disrupted by overlapping molecular defects. We postulate that impaired function of the INSIG–SCAP–SREBP2 complex, post-translational stabilization of HMGCR due to AMPK inactivation and defective ubiquitination, and chronic endocrine drive from insulin and cytokines jointly uncouple cholesterol synthesis from sterol feedback. Furthermore, epigenetic activation and microRNA modulation (notably miR-33a/b) reinforce persistent expression of cholesterol synthesis genes. This integrated “feedback-escape” model predicts that HMGCR half-life, phosphorylation, and transcriptional activity remain elevated independent of sterol levels, explaining both hypercholesterolemia and partial statin resistance. Experimental validation using hepatocyte models, genetic manipulations of INSIG or AMPK, and human biopsy or biomarker studies could establish metabolic feedback resistance as a key pathogenic mechanism. Restoring feedback sensitivity through AMPK activation, INSIG stabilization, or E3-ligase modulation may represent a novel therapeutic strategy for dyslipidemia and metabolic disease.